A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...

This came after the company in March was ordered to pay $60 million in compensation related to the death of a premature baby that was fed its Enfamil Premature 24 product. Nearly 1,000 such ...

Mead Johnson had already been ordered to pay $60m in damages in March to Jasmine Watson, the mother whose baby died after being fed the company’s Enfamil Premature 24 brand of formula.

Reckitt has also launched a strategic review of its troubled infant-formula unit Mead Johnson after it was ordered to pay a $60 million compensation in March related to the death of a premature ...

Reckitt saw sales surpass expectations in the third quarter as the consumer giant was boosted by healthcare brands, including Durex condoms and Nurofen.

Abbott said in July it may have to pull Similac for premature infants off shelves if juries continue ... allegations about both Abbott’s Similac formula and Reckitt’s Enfamil in a single case. The ...

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their ...

In the first case to go to trial in March, Reckitt Benckiser was ordered to pay $60 million in damages to a mother whose premature child died after consuming the company’s Enfamil baby formula.

in damages to the mother of a premature baby who died of NEC after being fed its Enfamil baby formula. 'There are still plenty of outstanding cases so this issue will not go away for Reckitt ...

Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...